Viral Infections and Antiviral Therapies provides comprehensive coverage of viral infections and their transmission. Coverage includes antiviral agents, therapeutics, their mechanisms and treatment strategies. The book is organized into four sections, including an introduction to antiviral therapies, viral infections and their transmission, antiviral agents and therapeutics, and a market overview and future developments. The chapters in each section of the book discuss various key topics that are contributed to by an international group of leading experts.
1. Section I: Introduction - p. xxii 2. Chapter 1. Introduction to antiviral therapy - p. 3 3. Section II: Viral infections and transmission - p. 16 4. Chapter 2. Emerging viral diseases - p. 25 5. Chapter 3. Evolution and transmission of viruses - p. 39 6. Chapter 4. Mode of viral infections and transmissions - p. 55 7. Chapter 5. Transmission and intervention dynamics of SARS-CoV-2 - p. 69 8. Chapter 6. Sexually transmitted viral infections - p. 85 9. Chapter 7. Testing viral infections - p. 99 10. Chapter 8. Electron microscopic methods for virus diagnosis - p. 121 11. Section III: Antiviral agents and therapeutics - p. 137 12. Chapter 9. Virotherapy - p. 143 13. Chapter 10. Challenges in designing antiviral agents - p. 169 14. Chapter 11. Anti-influenza agents - p. 211 15. Chapter 12. Anti-herpes virus agents - p. 241 16. Chapter 13. Antiretroviral therapy - p. 263 17. Chapter 14. Rotavirus and antirotaviral therapeutics: trends and advances - p. 285 18. Chapter 15. Current therapeutic strategies and novel antiviral compounds for the treatment of nonpolio enteroviruses - p. 303 19. Chapter 16. Antiviral agents against flaviviruses - p. 315 20. Chapter 17. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat - p. 339 21. Chapter 18. Herbal drugs to combat viruses - p. 377 22. Chapter 19. Strategies for delivery of antiviral agents - p. 407 23. Chapter 20. Nanovesicles for delivery of antiviral agents - p. 493 24. Chapter 21. Antiviral biomaterials - p. 519 25. Chapter 22. Antiviral biomolecules from marine inhabitants - p. 537 26. Chapter 23. Plant polysaccharides as antiviral agents - p. 567 27. Chapter 24. Antiviral peptides against dengue virus - p. 581 28. Chapter 25. mRNA vaccines for COVID-19 - p. 611 29. Chapter 26. Immunotherapy as an emerging and promising tool against viral infections - p. 625 30. Chapter 27. Role of nutraceuticals as immunomodulators to combat viruses - p. 653 31. Section IV: Others - p. 683 32. Chapter 28. In vitro and in vivo approaches for evaluating antiviral efficacy - p. 693 33. Chapter 29. Clinical Trials and Regulatory considerations of Antiviral agents - p. 709 34. Chapter 30. Future perspectives of antiviral therapy - p. 741 35. Index - p. 755
Viral Infections and Antiviral Therapies provides comprehensive coverage of viral infections and their transmission. Coverage includes antiviral agents, therapeutics, their mechanisms and treatment strategies. The book is organized into four sections, including an introduction to antiviral therapies, viral infections and their transmission, antiviral agents and therapeutics, and a market overview and future developments. The chapters in each section of the book discuss various key topics that are contributed to by an international group of leading experts.
1. Section I: Introduction - p. xxii 2. Chapter 1. Introduction to antiviral therapy - p. 3 3. Section II: Viral infections and transmission - p. 16 4. Chapter 2. Emerging viral diseases - p. 25 5. Chapter 3. Evolution and transmission of viruses - p. 39 6. Chapter 4. Mode of viral infections and transmissions - p. 55 7. Chapter 5. Transmission and intervention dynamics of SARS-CoV-2 - p. 69 8. Chapter 6. Sexually transmitted viral infections - p. 85 9. Chapter 7. Testing viral infections - p. 99 10. Chapter 8. Electron microscopic methods for virus diagnosis - p. 121 11. Section III: Antiviral agents and therapeutics - p. 137 12. Chapter 9. Virotherapy - p. 143 13. Chapter 10. Challenges in designing antiviral agents - p. 169 14. Chapter 11. Anti-influenza agents - p. 211 15. Chapter 12. Anti-herpes virus agents - p. 241 16. Chapter 13. Antiretroviral therapy - p. 263 17. Chapter 14. Rotavirus and antirotaviral therapeutics: trends and advances - p. 285 18. Chapter 15. Current therapeutic strategies and novel antiviral compounds for the treatment of nonpolio enteroviruses - p. 303 19. Chapter 16. Antiviral agents against flaviviruses - p. 315 20. Chapter 17. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat - p. 339 21. Chapter 18. Herbal drugs to combat viruses - p. 377 22. Chapter 19. Strategies for delivery of antiviral agents - p. 407 23. Chapter 20. Nanovesicles for delivery of antiviral agents - p. 493 24. Chapter 21. Antiviral biomaterials - p. 519 25. Chapter 22. Antiviral biomolecules from marine inhabitants - p. 537 26. Chapter 23. Plant polysaccharides as antiviral agents - p. 567 27. Chapter 24. Antiviral peptides against dengue virus - p. 581 28. Chapter 25. mRNA vaccines for COVID-19 - p. 611 29. Chapter 26. Immunotherapy as an emerging and promising tool against viral infections - p. 625 30. Chapter 27. Role of nutraceuticals as immunomodulators to combat viruses - p. 653 31. Section IV: Others - p. 683 32. Chapter 28. In vitro and in vivo approaches for evaluating antiviral efficacy - p. 693 33. Chapter 29. Clinical Trials and Regulatory considerations of Antiviral agents - p. 709 34. Chapter 30. Future perspectives of antiviral therapy - p. 741 35. Index - p. 755
